![]() |
||||
|
||||
|
|
||||
Re: NYTimes.com: Merck Asks for a Dismissal in First of Suits Over VioxxFrom: art fougner, md (evsono@pipeline.com)Wed Apr 13 14:58:22 2005
At Wed, 13 Apr 2005, RModugno@aol.com wrote: > >In a message dated 4/13/05 1:04:31 PM Eastern Daylight Time, >evsono@pipeline.com writes: > >Or Bendectin ... > >art > >At Wed, 13 Apr 2005, Larry Glazerman wrote: >> >>Here we go again. Memories of PremPro >> >>-- >>Larry R. Glazerman, MD >>Ob-Gyn at Trexlertown, PC >>larry.glazerman@lvh.com >> >Yeah, but it seems that the claim is fraudulent! The Vioxx samples that she >claims her husband took that "caused' his heart attack were sent to the Merck >distribution centers months AFTER her husband died! > >Robert Modugno MD MBA FACOG >Marietta, GA > >Robert Modugno MD MBA FACOG ALL the Bendectin claims were bogus ... didn't matter ... Bendectin became the first litogen. art
-- art fougner, md
|
|
Return to
|
Mail a New Message to the Forum: ob-gyn-l@obgyn.net Forum Administrator: geffrey.klein@obgyn.net Report Technical Problems: webmaster@obgyn.net Last Updated: Wed Jul 2 04:39:23 2008 |
The American Medical Association is no longer designating CME hours for AMA Category II CME credit. However, physicians themselves may self designate learning activities as Category II CME credit hours if they feel it is of sufficient educational merit and meets the formal definitions of continuing medical education. OBGYN.net believes these interaction in this forum meets these criteria. For further information see the AMA web site.